Search | Clinical Trials Finder

Conditions: Prematurity, Development Delay, Premature Birth
Interventions: Recorded Maternal Voice, Placebo Recording; Behavioral
Lead sponsor: University of New Mexico; Other
Eligibility: 28 Weeks to 33 Weeks
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Infant Development, Infant,Premature, Infant, Very Low Birth Weight, Infant, Small for Gestational Age, Infant Conditions
Interventions: Movement Intervention; Behavioral
Lead sponsor: University of Southern California; Other
Eligibility: 3 Months to 9 Months
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Women at Risk for Pregnancy
Interventions: VeraCept, ParaGard; Drug
Lead sponsor: Sebela Women's Health Inc.; Industry
Eligibility: Up to 45 Years · Female only
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2024
U.S. locations: 2
States / cities: Portland, Oregon • Seattle, Washington

Conditions: Endometrial Neoplasms
Interventions: Time Restricted Eating (TRE) Schedule; Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older · Female only
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Ovarian Diseases, Ovarian Neoplasms
Interventions: Laboratory Tumor Marker Analysis, Transvaginal Ultrasound, Health Status Questionnaire; Other
Lead sponsor: Swedish Medical Center; Other
Eligibility: 30 Years and older · Female only
Enrollment: 534 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2015
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Acute Kidney Injury (AKI)
Interventions: ASP1128, Placebo; Drug
Lead sponsor: Astellas Pharma Inc; Industry
Eligibility: 35 Years and older
Enrollment: 351 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 27
States / cities: Huntsville, Alabama • Tucson, Arizona • Clearwater, Florida + 23 more

Conditions: Prenatal Alcohol Exposure, Fetal Alcohol Spectrum Disorders
Interventions: Families Moving Forward Bridges; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 6 Months and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Shoreline, Washington

Conditions: Treponema Pallidum, Treponema Pallidum Infection, Syphilis Infection, Serum, Plasma, Blooddraw, Sexually Transmitted Infection (STI)
Interventions: ALPCO Syphilis-T, ALPCO Syphilis-NT CLIA Kits; Device
Lead sponsor: American Laboratory Products Company; Industry
Eligibility: 13 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 6
States / cities: Lancaster, California • Los Angeles, California • North Miami, Florida + 3 more

Conditions: Premature Birth
Interventions: Brain Training (Active), Brain Training (Passive), Brain Training (Active or Passive); Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 4 Years to 5 Years
Enrollment: 57 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Stanford, California

Conditions: Post Partum Depression, Perinatal Depression
Interventions: Stress reduction program 'A', Stress reduction program 'B'; Behavioral
Lead sponsor: Kaiser Permanente; Other
Eligibility: 18 Years and older · Female only
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Oakland, California

Conditions: Acute Kidney Injury
Interventions: Niyad (nafamostat mesylate), Placebo (0.9% NaCl); Device
Lead sponsor: Talphera, Inc; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 10
States / cities: Los Angeles, California • Orlando, Florida • Detroit, Michigan + 7 more

Conditions: Weight Loss, Postpartum Weight Retention, Hypertension in Pregnancy, Diabetes Mellitus in Pregnancy, Preeclampsia, Recruitment
Interventions: Online Behavioral Weight Loss Program, Virtual weigh-in; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older · Female only
Enrollment: 89 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Fertility
Interventions: Education for pregnancy planning; Behavioral
Lead sponsor: Michigan State University; Other
Eligibility: 18 Years to 34 Years · Female only
Enrollment: 198 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: East Lansing, Michigan

Conditions: Cardiac Surgery With Cardiopulmonary Bypass
Interventions: Fenoldopam; Drug
Lead sponsor: Summa Health System; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: Akron, Ohio

Conditions: Women Admitted to Labor and Delivery for the Management of Preterm Labor and/or Preterm Premature Rupture of Membranes (PPROM)
Interventions: Not listed
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Pulmonary Hypertension, Infant, Premature
Interventions: Not listed
Lead sponsor: Mount Sinai Hospital, Canada; Other
Eligibility: 14 Days and older
Enrollment: 350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Pregnancy
Interventions: 8% progesterone vaginal gel, Placebo Vaginal Gel; Drug
Lead sponsor: Juniper Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 636 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2009
U.S. locations: 45
States / cities: Mobile, Alabama • Tucson, Arizona • Colton, California + 39 more

Conditions: Gestational Diabetes Mellitus, Pregnancy Complications
Interventions: Not listed
Lead sponsor: Long Island University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 65 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Diabetic Nephropathy
Interventions: Lisinopril, Nifedipine, Simvastatin; Drug
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1993 – 1999
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Intrauterine Adhesion
Interventions: Juveena Hydrogel System, Transcervical Gynecologic Procedures (TCGP); Device · Procedure
Lead sponsor: Rejoni Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 15
States / cities: Phoenix, Arizona • San Francisco, California • Washington D.C., District of Columbia + 11 more

Conditions: Pre-Eclampsia
Interventions: Acetylsalicylic Acid 81 mg, Acetylsalicylic Acid 162 mg, Control; Drug · Other
Lead sponsor: John O'Brien, MD; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 208 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Ovarian Cancer, Breast Cancer
Interventions: Questionnaire; Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 176 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2008
U.S. locations: 4
States / cities: Birmingham, Alabama • Los Angeles, California • New York, New York + 1 more

Conditions: Cascade Testing, Lynch Syndrome, Decision Making, Colorectal Cancer, Uterine Cancer, Cancer Prevention
Interventions: Information Letter and Booklet, Information Letter; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 185 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Gestational Diabetes Mellitus
Interventions: Metformin, Placebo; Drug
Lead sponsor: Intermountain Health Care, Inc.; Other
Eligibility: 18 Years to 45 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 1
States / cities: Murray, Utah

Search by objective public record fields.

Maternal Voice and Quantitative EEG (qEEG)

Movement-based Infant Intervention

A PK Study Comparing VeraCept vs. ParaGard Intrauterine Devices (IUDs)

Time Restricted Eating (TRE) Among Native Hawaiian/Pacific Islander Women at Risk for Endometrial Cancer

Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer

Study to Evaluate the Efficacy of ASP1128 (MA-0217) in Subjects at Risk for Acute Kidney Injury (AKI) Following Coronary Artery Bypass Graft (CABG) and/or Valve Surgery

Families Moving Forward Bridges: An Early Intervention for Infants and Toddlers With PAE With or At-risk for FASD

This Study Evaluates the ALPCO Syphilis-T and Syphilis-NT CLIA Kits for Detecting Syphilis Antibodies in Serum and Plasma. Samples From At-risk, HIV-positive, Pregnant, and Healthy Individuals Will Assess Assay Performance Versus Established Comparator Tests.

Brain Training in Preterm Children at Risk for Inattention, Hyperactivity, and Executive Function Impairment

mHealth Mindfulness Intervention for Pregnant Black and Latina Women at Risk of Postpartum Depression

Nafamostat Efficacy in Phase 3 Registrational CRRT Study

Postpartum Weight Loss for Women at Elevated Cardiovascular Risk

Usefulness of Home Pregnancy Testing

A Pilot Study to Investigate Fenoldopam Usage in the Prevention of Postoperative Renal Dysfunction in Patients at a High Risk for Renal Impairment During Cariopulmonary Bypass for Cardiac Surgery

Fetal Thymus Involution as a Predictor of Adverse Neonatal Outcomes

Novel Echocardiographic Methods for Early Identification of Neonates at Risk for Chronic Pulmonary Hypertension

Vaginal Progesterone to Reduce the Risk of Another Preterm Birth

Gestational Diabetes Mellitus (GDM) in Pregnant Women

Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2 Diabetes

Safety and Effectiveness of Juveena™ Hydrogel System Following Transcervical Gynecologic Procedures (TCGP) At High-Risk for Intrauterine Adhesions

Role of ASpirin in Placental and Maternal Endothelial Cell Regulation IN Pre-eclampsia

Lynne Cohen Consortium Project: Multi-Center Database/Registry

Initial Testing of a Behavioral Intervention About Genetic Services for Families at Risk of Lynch Syndrome

Early Intervention for Gestational Diabetes